SPECCHIA, GIORGINA
 Distribuzione geografica
Continente #
NA - Nord America 3.978
EU - Europa 2.498
AS - Asia 2.101
SA - Sud America 245
Continente sconosciuto - Info sul continente non disponibili 46
AF - Africa 31
OC - Oceania 6
Totale 8.905
Nazione #
US - Stati Uniti d'America 3.939
CN - Cina 977
IE - Irlanda 710
UA - Ucraina 604
SG - Singapore 550
SE - Svezia 385
RU - Federazione Russa 383
BR - Brasile 203
HK - Hong Kong 190
TR - Turchia 160
FR - Francia 104
FI - Finlandia 98
GB - Regno Unito 85
IN - India 81
VN - Vietnam 70
IT - Italia 42
DE - Germania 40
CA - Canada 21
AR - Argentina 19
IQ - Iraq 17
MX - Messico 10
ZA - Sudafrica 10
BD - Bangladesh 9
CZ - Repubblica Ceca 9
AT - Austria 8
PK - Pakistan 8
ES - Italia 7
PL - Polonia 6
UZ - Uzbekistan 6
AU - Australia 5
DZ - Algeria 5
EC - Ecuador 5
JP - Giappone 5
LT - Lituania 5
EU - Europa 4
JM - Giamaica 4
MA - Marocco 4
NL - Olanda 4
SA - Arabia Saudita 4
UY - Uruguay 4
CO - Colombia 3
KE - Kenya 3
LB - Libano 3
PY - Paraguay 3
VE - Venezuela 3
BE - Belgio 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
HN - Honduras 2
ID - Indonesia 2
KZ - Kazakistan 2
MU - Mauritius 2
OM - Oman 2
PS - Palestinian Territory 2
TN - Tunisia 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CY - Cipro 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 8.863
Città #
Dublin 708
San Jose 507
Chandler 503
Jacksonville 425
Dearborn 357
Singapore 266
Nanjing 264
Nyköping 210
Hong Kong 190
Ashburn 151
Beijing 135
Nanchang 118
Santa Clara 97
Princeton 91
Council Bluffs 86
San Mateo 86
Boardman 78
Columbus 76
Wilmington 75
Lauterbourg 69
Moscow 65
Dallas 58
Shenyang 49
Jiaxing 42
Kunming 40
Tianjin 40
The Dalles 37
Woodbridge 26
Hebei 25
Ho Chi Minh City 23
Hangzhou 21
Changsha 20
New York 20
Des Moines 19
Zhengzhou 19
Jinan 17
Los Angeles 17
São Paulo 15
Guangzhou 14
Changchun 13
Shanghai 13
Chicago 12
Chennai 11
Helsinki 11
Munich 11
Ningbo 11
Auburn Hills 10
Frankfurt am Main 9
Charlotte 8
Hanoi 8
Lanzhou 8
London 8
Rio de Janeiro 8
San Francisco 8
Atlanta 7
Brooklyn 7
Johannesburg 7
Norwalk 7
Hilden 6
Tashkent 6
Toronto 6
Wuhan 6
Belo Horizonte 5
Brasília 5
Brno 5
Da Nang 5
Milan 5
Monza 5
Pittsburgh 5
Taizhou 5
Turku 5
Warsaw 5
Amsterdam 4
Baghdad 4
Boston 4
Houston 4
Kingston 4
Leawood 4
Miami 4
Olomouc 4
Pelotas 4
Secaucus 4
Tokyo 4
Ann Arbor 3
Buffalo 3
Campo Grande 3
Caxias do Sul 3
Curitiba 3
Dhaka 3
Goiânia 3
Haiphong 3
Hải Dương 3
Jinhua 3
Manchester 3
Mumbai 3
Nuremberg 3
Orem 3
Ottawa 3
Phoenix 3
Porto Alegre 3
Totale 5.405
Nome #
T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. 154
Autoimmune myelofibrosis: report of three cases and review of the literature. 143
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11). 140
Mobilization of haematopoietic stem cells CD34+ in patients undergoing elective lung resection: observational pilot study 140
Acute megakaryoblastic leukemia: experience of GIMEMA trials. 138
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. 132
Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. 131
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 131
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. 128
Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment. 126
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. 125
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP-6 125
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 122
CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. 121
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. 119
Acute mixed lineage leukemias. 117
A case of Sezary's syndrome with terminal "leukemic phase". 117
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature 116
t(15;17) in acute promyelocytic leukemia is not associated with submicroscopic deletions on der(17) 116
Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies. 114
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients. 114
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia. 113
Angiogenesis and hereditary hemorrhagic telangiectasia. Rendu-Osler-Weber disease. 113
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. 113
Extramedullary blast crisis in chronic myeloid leukemia 111
Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. 111
Continuous infusion chemotherapy with epirubicin and vincristine in relapsed and refractory acute leukemia. 111
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. 110
CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. 110
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. 108
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 108
Non-treatment-related chronic myeloid leukemia as a second malignancy. 108
Acute promyelocytic leukemia: morphological aspects. 107
Submicroscopic deletions in an acute myeloid leukemia case with a four-way t(8;11;16;21). 106
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells. 105
Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patients. 104
Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia. 104
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. 103
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH). 103
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia. 100
Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia. 100
Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears 100
Fungemia in acute leukemia patients: a single institution's experience. 99
Cytotoxic activity and mechanism of action of 5-Aza-2'-deoxycytidine in human CML cells. 98
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes. 98
Cytochemical "normal" and "abnormal" eosinophils in acute leukemias. 98
Pneumonia in acute leukemia patients during induction therapy: experience in a single institution. 98
Molecular cytogenetic study of chromosomal instability at 1q21-32 in an adult acute lymphoblastic leukemia case. 97
Sensitivity to imatinib but low frequency of the TEL/PDGFRb fusion protein in chronic myelomonocytic leukemia. 97
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. 96
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a Ph-positive chronic myeloid leukemia. 96
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. 95
Familial clustering of HTLV-I infection in southeastern Italy 95
Molecular cytogenetics characterization of a novel translocation involving chromosomes 17 and 19 in a Ph+ adult acute lymphoblastic leukaemia. 95
Typhlitis complicating induction therapy in adult acute myeloid leukemia. 95
Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines. 95
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia. 94
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 93
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. 93
Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome? 93
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia. 93
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases. 92
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto. 92
Cytophagocytosis by the blast cells in acute myeloid leukemia. 92
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. 91
Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies. 91
Monocytes with binding capacity to sheep red blood cells in a case of acute undifferentiated leukemia. 91
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'? 91
Mitoxantrone and continuous infusion of cytosine arabinoside in refractory and relapsed acute lymphoblastic leukemia. 90
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. 89
Liquid chromatographic determination of urinary 5-methyl-2'-deoxycytidine and pseudouridine as potential biological markers for leukaemia. 89
Genomic deletions on the third chromosome involved in variant t(9;22) chronic myeloid leukaemia cases 89
Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. 89
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 87
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. 87
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. 87
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA 87
The MDR phenotype in acute nonlymphoid leukemia. 87
Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemia. 86
Reciprocal translocation t(12;13)(p13;q14) in acute nonlymphoblastic leukemia: report and cytogenetic analysis of two cases. 84
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. 83
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials. 82
Therapy of molecular relapse in acute promyelocytic leukemia. 81
Hand-mirror (HM) cells in acute lymphoblastic leukaemia (A.L.L.). An attempt at cellular classification by morphometric analytical parameters using the S.A.M. (Shape Analytical Morphometry) system. 81
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. 79
Immunophenotypic and molecular features of 'cuplike' acute myeloid leukemias 73
Totale 8.905
Categoria #
all - tutte 43.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022302 0 0 0 1 11 4 8 28 67 40 25 118
2022/20231.929 136 56 50 171 158 176 0 176 915 8 49 34
2023/2024246 78 11 16 16 28 49 3 12 3 1 2 27
2024/20251.130 50 7 6 53 44 149 135 60 315 88 106 117
2025/20261.758 81 72 131 205 87 136 396 227 222 125 37 39
2026/2027408 28 213 164 3 0 0 0 0 0 0 0 0
Totale 8.905